Literature DB >> 19934656

AGTR1 as a therapeutic target in ER-positive and ERBB2-negative breast cancer cases.

Bushra Ateeq, Scott A Tomlins, Arul M Chinnaiyan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19934656      PMCID： PMC2940713          DOI： 10.4161/cc.8.23.9976

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  14 in total

1.  Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.

Authors:  K Krishnamurthi; J G Verbalis; W Zheng; Z Wu; L B Clerch; K Sandberg
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

2.  The genomic organization of the rat AT1 angiotensin receptor.

Authors:  K Langford; K Frenzel; B M Martin; K E Bernstein
Journal:  Biochem Biophys Res Commun       Date:  1992-03-31       Impact factor: 3.575

3.  Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.

Authors:  Takayasu Suganuma; Kazuhiko Ino; Kiyosumi Shibata; Hiroaki Kajiyama; Tetsuro Nagasaka; Shigehiko Mizutani; Fumitaka Kikkawa
Journal:  Clin Cancer Res       Date:  2005-04-01       Impact factor: 12.531

4.  Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation.

Authors:  M Jamaluddin; T Meng; J Sun; I Boldogh; Y Han; A R Brasier
Journal:  Mol Endocrinol       Date:  2000-01

5.  Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk.

Authors:  Angela M González-Zuloeta Ladd; Alejandro Arias Vásquez; Fakhredin A Sayed-Tabatabaei; J W Coebergh; Albert Hofman; Omer Njajou; Bruno Stricker; Cornelia van Duijn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-09       Impact factor: 4.254

6.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

7.  Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.

Authors:  Stephen C Benson; Harrihar A Pershadsingh; Christopher I Ho; Amar Chittiboyina; Prashant Desai; Michal Pravenec; Nianning Qi; Jiaming Wang; Mitchell A Avery; Theodore W Kurtz
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

8.  AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist.

Authors:  Daniel R Rhodes; Bushra Ateeq; Qi Cao; Scott A Tomlins; Rohit Mehra; Bharathi Laxman; Shanker Kalyana-Sundaram; Robert J Lonigro; Beth E Helgeson; Mahaveer S Bhojani; Alnawaz Rehemtulla; Celina G Kleer; Daniel F Hayes; Peter C Lucas; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

9.  Molecular structure and transcriptional function of the rat vascular AT1a angiotensin receptor gene.

Authors:  K Takeuchi; R W Alexander; Y Nakamura; T Tsujino; T J Murphy
Journal:  Circ Res       Date:  1993-10       Impact factor: 17.367

10.  Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.

Authors:  M A Redondo-Müller; M Stevanovic-Walker; S Barker; J R Puddefoot; G P Vinson
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678
View more
  11 in total

1.  Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer.

Authors:  Krithika Krishnarao; Katelyn A Bruno; Damian N Di Florio; Brandy H Edenfield; Emily R Whelan; Logan P Macomb; Molly M McGuire; Anneliese R Hill; Jordan C Ray; Lauren F Cornell; Winston Tan; Xochiquetzal J Geiger; Gary R Salomon; Erika J Douglass; DeLisa Fairweather; Mohamad H Yamani
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

2.  PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.

Authors:  Fang Wang; Liqiong Yang; Mintao Xiao; Zhuo Zhang; Jing Shen; Songyot Anuchapreeda; Singkome Tima; Sawitree Chiampanichayakul; Zhangang Xiao
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

Review 3.  Recent progress in targeting cancer.

Authors:  Zoya N Demidenko; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-12       Impact factor: 5.682

Review 4.  Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases.

Authors:  Anukriti Singh; Jessica J Nunes; Bushra Ateeq
Journal:  Eur J Pharmacol       Date:  2015-05-14       Impact factor: 4.432

5.  The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.

Authors:  Rhiannon Coulson; Seng H Liew; Angela A Connelly; Nicholas S Yee; Siddhartha Deb; Beena Kumar; Ana C Vargas; Sandra A O'Toole; Adam C Parslow; Ashleigh Poh; Tracy Putoczki; Riley J Morrow; Mariah Alorro; Kyren A Lazarus; Evie F W Yeap; Kelly L Walton; Craig A Harrison; Natalie J Hannan; Amee J George; Colin D Clyne; Matthias Ernst; Andrew M Allen; Ashwini L Chand
Journal:  Oncotarget       Date:  2017-03-21

6.  The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.

Authors:  Caterina Marchiò; Patrizia Dell'Orto; Laura Annaratone; Felipe C Geyer; Tiziana Venesio; Enrico Berrino; Ludovica Verdun di Cantogno; Andrea Garofoli; Nelson Rangel; Laura Casorzo; Carmine dell'Aglio; Patrizia Gugliotta; Elena Trisolini; Alessandra Beano; Francesca Pietribiasi; Renzo Orlassino; Paola Cassoni; Achille Pich; Filippo Montemurro; Marcella Mottolese; Anne Vincent-Salomon; Frédérique Penault-Llorca; Enzo Medico; Charlotte K Y Ng; Giuseppe Viale; Anna Sapino
Journal:  Am J Surg Pathol       Date:  2018-09       Impact factor: 6.394

7.  Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.

Authors:  Shumei Zhang; Yihan Wang; Yue Gu; Jiang Zhu; Ce Ci; Zhongfu Guo; Chuangeng Chen; Yanjun Wei; Wenhua Lv; Hongbo Liu; Dongwei Zhang; Yan Zhang
Journal:  Mol Oncol       Date:  2018-05-21       Impact factor: 6.603

8.  Supporting precision medicine by data mining across multi-disciplines: an integrative approach for generating comprehensive linkages between single nucleotide variants (SNVs) and drug-binding sites.

Authors:  Amrita Roy Choudhury; Tiejun Cheng; Lon Phan; Stephen H Bryant; Yanli Wang
Journal:  Bioinformatics       Date:  2017-06-01       Impact factor: 6.937

9.  Repurposing ARBs as treatments for breast cancer.

Authors:  Amee J George; Andrew Allen; Ashwini L Chand
Journal:  Aging (Albany NY)       Date:  2017-05-31       Impact factor: 5.682

10.  TBX2 Identified as a Potential Predictor of Bone Metastasis in Lung Adenocarcinoma via Integrated Bioinformatics Analyses and Verification of Functional Assay.

Authors:  Huajian Yu; Fangyu Zhao; Jing Li; Kechao Zhu; Hechun Lin; Zhen Pan; Miaoxin Zhu; Ming Yao; Mingxia Yan
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.